|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070679
Gebhardt et al. • Figure S1 Differences in the size and grade of wt and Rage−/− tumors.
• Figure S2 Rage−/− tumors show reduced levels of BrdU- and phospho–c-Jun–positive tumor cells and less infiltrating innate immune cells.
• Figure S3 Initiation with DMBA does not affect the response to single TPA treatment in wt and Rage−/− mice.
• Figure S4 Expression of proinflammatory proteins in chemically induced tumors.
• Figure S5 Impaired expression of proinflammatory proteins in TPA-treated skin.
• Figure S6 Dermal infiltration and epidermal hyperplasia in Rage−/− mice is restored by accelerated TPA treatment.
• Figure S7 Impaired epidermal hyperplasia of Rage−/− skin after DMBA/TPA treatment.
• Figure S8 S100a8, S100a9, and RAGE expression in different cell types of chemically induced skin tumors.
• Figure S9 Tnf-α protein levels in tumor sections derived from the accelerated carcinogenesis protocol.
• Tables S1 and S2 (PDF)
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
